FGF23 and chronic kidney disease: Despite promising therapeutic implications in targeting FGF23 signaling, further research is imperative to elucidate its precise mechanisms and potential therapeutic benefits, particularly in chronic kidney disease where elevated FGF23 levels contribute to adverse outcomes.